DNA methylation-based classification of central nervous system tumours

2018/03/13 by David Capper, David Jones, David T. W. Jones +155 · 31 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Glioma Diagnosis and Treatment #Epigenetics and DNA Methylation #Cancer Genomics and Diagnostics

paper · doi:10.1038/nature26000

Citations

• VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY

Cited by

• Ultra-fast deep-learned CNS tumour classification during surgery
• Proneural–mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import
• DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma
• Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard
• Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue
• The Epigenetic Hallmarks of Cancer
• Digital Biopsy and Network Analysis of Dynamic [ ⁶⁸ Ga]Ga-FAPI-46 Data in Patients with Malignant and Benign Pancreatic Lesions
• Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
• Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM
• Computational Methods for Data Integration and Imputation of Missing Values in <i>Omics</i> Datasets
• Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas
• Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
• FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
• Molecular signatures define <i>BAP1</i>-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
• Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
• Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
• Intelligence, physics and information -- the tradeoff between accuracy and simplicity in machine learning
• ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis
• Human-Expert-Level Brain Tumor Detection Using Deep Learning with Data Distillation and Augmentation
• Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma
• Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges
• A ternary-code DNA methylome atlas of mouse tissues
• The prognostic impact of <i>CDKN2A/B</i> hemizygous deletions in meningioma
• Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
• Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort
• cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas
• A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities
• Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
• Accurate calling of <i>KIAA1549‐BRAF</i> fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data
• Inflammasome Dynamics in Psoriasis: AIM2, NLRP3, and NLRP1 at the Interface of Inflammation and Immunity